Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Doximity (DOCS) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank emphasizes companies with positive estim ...

It's a welcome sight for shareholders who haven't had much to rejoice about lately. What a difference a day can make. Until Aug. 8, shares of Doximity (DOCS 0.69%), a healthcare-focused networking platform, were in the red for the year. However, on Aug. 9, the company's stock skyrocketed by more than 33%, making its year-to-date performance better than that of the broader market. As investors might guess, Doximity's gains had something to do with its latest quarterly report, but even after this jump, shares ...

Morsa Images Pondering the issue of sustainable growth Earlier this month, Doximity, whose shares had been languishing in investor purgatory for most of 2024 reported its results for fiscal Q1 2025. The results were significantly better than had been anticipated with revenues of $127 million compared to the prior forecast of $120 million, and adjusted EBITDA of $66 million compared to a prior forecast of $56 million. Year over year revenue growth was 17% while the adjusted EBITDA rose by 42% and the adjuste ...

Doximity Today DOCS Doximity $36.21 +0.18 (+0.50%) 52-Week Range $19.71 ▼ $37.25 P/E Ratio 50.29 Price Target $31.27 Add to Watchlist Doximity Inc. NASDAQ: DOCS is a digital professional medical networking platform that is a cross between LinkedIn and Meta Platforms Inc. NASDAQ: META Facebook. The platform enables physicians to connect with their colleagues to collaborate on patient treatments and research. It also provides the latest medical news and research and provides access to various career tools. Do ...

Solskin Introduction & Investment Thesis I last wrote about Doximity (NYSE:DOCS) in April, where I rated the stock a "hold." Although I stated that the stock has a potential upside of at least 29% from its levels back then, I believed that investors would be weary until the management could reignite the growth story. Since then, the stock has climbed 45% as it reported a strong Q1 FY25 earnings report, where revenue and Adjusted EBITDA grew 17% and 41% YoY, respectively, beating estimates. Simultaneously, t ...

A solid earnings report lifted the health tech stock. Shares of Doximity (DOCS 35.19%), the social network for doctors, were jumping today after the company easily beat estimates in its fiscal first-quarter earnings report. The stock was up 33.1% as of 1:04 p.m. ET on the news. Doximity delights The social media company reported revenue growth of 17% to $126.7 million in the period ended June 30, which easily beat the consensus estimate of $119.9 million. Profit growth soared as well with adjusted earnings ...

Doximity (NYSE:DOCS) stock is rising higher on Friday following the release of the medical cloud-based digital platform company's earnings report for its fiscal first quarter of 2025. That earnings report starts off strong with adjusted EPS of 28 cents per share. This is better than the 23 cents per share Wall Street was expecting. It's also an improvement over the 19 cents per share reported in the same period of the year prior. Adding to this is revenue of $126.7 million in fiscal Q1. That's another beat ...

Start Time: 17:00 January 1, 0000 5:50 PM ET Doximity, Inc. (NYSE:DOCS) Q1 2025 Earnings Conference Call August 08, 2024, 17:00 PM ET Company Participants Jeff Tangney - Co-founder and CEO Nate Gross - Co-founder and CSO Anna Bryson - CFO Perry Gold - VP of IR Conference Call Participants Brian Peterson - Raymond James Scott Berg - Needham & Company Stephanie Davis - Barclays Jared Hass - William Blair John Pinney - Canaccord Genuity Allen Lutz - Bank of America Elizabeth Anderson - Evercore ISI Jessica Tas ...

Doximity (DOCS) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 27.27%. A quarter ago, it was expected that this medical social networking site would post earnings of $0.20 per share when it actually produced earnings of $0.25, delivering a surprise of 25%. Over the last four quarters ...

Table of Contents Title of each class Trading Symbol(s) Name of exchange on which registered DOCS The New York Stock Exchange Class A common stock, $0.001 par value per share UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________________________________________________________ FORM 10-Q _________________________________________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPO ...